NRIX insider files to sell 28,935 shares

Christine Ring reported the resale of 28,935 shares of Common Stock under Rule 144.

Rhea-AI Filing Summary

Christine Ring reported the resale of 28,935 shares of Common Stock under Rule 144. The filing lists 28,935 shares as securities to be sold via exercise of stock options for cash. The notice also itemizes recent 10b5-1 sales during April–June 2026 with per-trade share counts and proceeds.

Key Figures

Shares listed to be sold: 28,935 shares Example sale on 06/02/2026: 8,148 shares Example sale on 05/04/2026 (row 1): 3,368 shares +4 more

7 metrics

Shares listed to be sold 28,935 shares Securities To Be Sold; Exercise of Stock Options

Example sale on 06/02/2026 8,148 shares 10b5-1 sale on 06/02/2026 for $135,252.73

Example sale on 05/04/2026 (row 1) 3,368 shares 10b5-1 sale on 05/04/2026 for $57,118.25

Example sale on 05/04/2026 (row 2) 4,780 shares 10b5-1 sale on 05/04/2026 for $81,091.74

Example sale on 05/01/2026 5,394 shares Sale on 05/01/2026 for $90,406.68

Example sale on 04/30/2026 3,214 shares Sale on 04/30/2026 for $53,497.99

Example sale on 04/02/2026 8,148 shares 10b5-1 sale on 04/02/2026 for $124,148.63

Key Terms

10b5-1, Rule 144, Exercise of Stock Options

3 terms

10b5-1 regulatory

"10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Rule 144 regulatory

"Form 144 filing context (implied by form type and resale notice)"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of Stock Options financial

"Securities To Be Sold | Exercise of Stock Options | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did NRIX insider Christine Ring file in this Form 144?

She filed notice to sell 28,935 shares of Common Stock under Rule 144. The filing states the shares to be sold arise from the exercise of stock options for cash and lists recent 10b5-1 sales in April–June 2026 with amounts and proceeds.

How many shares does the filing list as to be sold for NRIX?

The filing lists 28,935 shares as the securities to be sold. That quantity is labeled under "Securities To Be Sold" and tied to an exercise of stock options; the filing separately shows multiple prior 10b5-1 transactions with individual share counts and proceeds.

Were any prior sales disclosed in the Form 144 for Christine Ring?

Yes. The filing itemizes multiple 10b5-1 sales during April–June 2026. Examples include 8,148 shares on 06/02/2026 for $135,252.73 and other trades in May and April with listed share counts and cash proceeds.

Does the Form 144 state how the shares were obtained?

Yes. The securities to be sold are described as arising from an "Exercise of Stock Options" and to be sold for cash. The filing pairs the 28,935-share amount with that exercise description in the securities-to-be-sold section.

Does this filing indicate who is acting as broker for the transactions?

Yes. The broker is identified as Morgan Stanley Smith Barney LLC, Executive Financial Services. The broker’s address and a NASDAQ listing reference appear in the securities/broker section of the filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001817199
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NURIX THERAPEUTICS INC
SEC File Number	001-39398
Address of Issuer	1600 Sierra Point Parkway Brisbane CALIFORNIA 94005
Phone	4156605320
Name of Person for Whose Account the Securities are To Be Sold	CHRISTINE RING
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	28935	558445.50	103405813	06/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2026	Exercise of Stock Options	Issuer			28935	06/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	06/02/2026	8148	135252.73
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	05/04/2026	3368	57118.25
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	05/04/2026	4780	81091.74
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	05/01/2026	5394	90406.68
CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	04/30/2026	3214	53497.99
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	04/02/2026	8148	124148.63

144: Remarks and Signature

Remarks
Date of Notice	06/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christine Ring
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)